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Introduction
Colonisation by Helicobacter pylori is known to cause 
chronic gastritis and leads to the development of severe 
gastroduodenal diseases such as peptic ulcer, lymphoma 
of the mucosa associated lymphoid tissue (MALT), or 
gastric adenocarcinoma [1]. Helicobacter pylori infection 
is associated with gastritis and considerable infiltration of 
neutrophils, monocytes, and lymphocytes into the gastric 
mucosa, which contribute to maintaining and expanding 
local inflammation. Activation and migration of these in-
flammatory cells into the gastric mucosa is related to in-
creased production of pro-inflammatory cytokines, which 
are believed to contribute in maintaining the gastric in-
flammation and causing epithelial cell damage [2-4]. The 
risk of different clinical expression of H. pylori infection 
is thought to rely on interaction between the host genetic 
factors and bacterial factors. For instance, polymorphisms 
of pro-inflammatory cytokine genes such as interleukin 
(IL)-8, IL-10, IL-17, IL-1a, and tumor necrosis factor a 
(TNF-a), which enhance inflammatory response of gastric 
mucosa and have been correlated to an increased risk of 
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Abstract
Helicobacter pylori (H. pylori) infection is associated with gastritis and marked infiltration of 
the gastric mucosa by several cytokines secreting inflammatory cells. Different clinical forms of the 
infection may reflect distinctive patterns of cytokine expression. Interleukin (IL)-17, IL-21, IL-22, and 
IL-23 have been reported to be involved in H. pylori-induced gastric mucosal inflammation, but the 
details and relationship to different patterns of inflammation and virulence factors remain unclear. 
The present study was launched to analyse IL-6 expression in H. pylori-infected and uninfected gas-
tric patients and to investigate its correlation with chronic gastritis among H. pylori-infected pa-
tients. Total RNA was extracted from the gastric antrum biopsies of 48 H. pylori-infected patients and  
38 H. pylori uninfected patients. Mucosal IL-21 mRNA expression level in H. pylori-infected and unin-
fected gastric biopsy was determined by real-time PCR. The presence of vacA (vacuolating cytotoxin 
A) and cagA (cytotoxin associated gene A) virulence factors were evaluated using PCR. Interleu-
kin-21 mRNA expression was significantly high in biopsies of H. pylori-infected patients compared to 
H. pylori uninfected patients, and the mucosal IL-21 mRNA level was positively correlated with the 
grade of chronic inflammation. There was no association between virulence factors and IL-21 mRNA 
expression. We believe that IL-21 might be involved in the pathogenesis of H. pylori and might be an 
index of the severity of chronic gastritis.
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gastric cancer and peptic ulcer [5, 6]. It has been shown 
that the mucosal levels of several cytokines were signifi-
cantly higher in H. pylori-infected patients with virulence 
factors in comparison to H. pylori-infected patients without 
virulence factors [7, 8]. It is suggested that the clinical out-
come of H. pylori infection is linked to certain strains such 
as the cytotoxin-associated gene (cagA) and vacuolating 
cytotoxin (vacA) [9]. The cagA gene, which is a marker 
for the presence of a pathogenicity island (cagPAI), has 
been shown to be involved in induction of pro-inflamma-
tory chemokine release, which is also associated with more 
severe gastritis and higher prevalence of peptic ulcer and 
gastric cancer [10-12]. Vacuolating cytotoxin A has two 
variable parts: the s (signal peptide) region exists as allele 
s1 or s2; and the m (middle) region occurs as m1 or m2 
allelic types. The allele combination of s1 m1 confers high, 
the s1 m2 intermediate, and the s2 m2 low toxin activi-
ty. The vacA s1 strain is mostly cagA-positive, thus the 
two markers are closely related [13]. There are geographic 
differences between vacA status and H. pylori-related dis-
eases. In Western countries infection with vacA s1 strain 
is more common in patients with peptic ulcer than in those 
with chronic gastritis. However, in Asian populations the 
association between vacA diversity and clinical outcome 
is not established [14]. Interleukin-21 (IL-21) is a four-he-
lix bundle cytokine that is produced by activated CD4+ 
T cells and natural killer T (NKT) cells [15, 16]. T follic-
ular helper (Tfh) cells also produce IL-21, which regulates 
generation of humoral responses and germinal centre for-
mation [17]. Interleukin-21 can stimulate non-immune cells 
to synthesise various inammatory molecules [15]. Helper 
T cells that produce IL-17 (‘TH-17 cells’) are distinct 
subsets of pro-inflammatory cells whose in vivo function 
requires IL-23 but whose in vitro differentiation requires 
only IL-6 and transforming growth factor-β1 (TGF-β1). 
Studies have demonstrated that IL-6 induces expression 
of IL-21 that amplifies an autocrine loop to induce more 
IL-21 and IL-23 receptors in naive CD4+ T cells. Both 
IL-23 and IL-21, along with TGF-β1, induce IL-17 ex-
pression independently of IL-6. Interleukin-21 and IL-23 
induce the orphan nuclear receptor RORγt, which in syn-
ergy with STAT3 enhances IL-17 expression. ‘TH-17’ 
cells produce IL-17, IL-17F, IL-21, and IL-22, which are 
thought to be required for the control of a variety of bac-
terial and fungal infections at mucosal surfaces [18, 19]. 
High levels of IL-21 expression occur in human Th1-as-
sociated diseases, and administration of IL-21 to mice en-
hances the inux of immune cells into inamed tissues and 
the severity of immune-mediated diseases [20, 21]. In the 
light of this study, it is conceivable that IL-21 may play an 
important role in the initiation and perpetuation of chronic 
infiammatory processes and may be associated with viru-
lence factors. We have therefore sought to determine the 
role of IL-21 in H. pylori-associated gastritis. We first-
ly examined IL-21 in the gastric mucosa of patients with 
H. pylori infection. Secondly, we evaluated the effect of 
virulence factors cagA and vacA allelic variants in H. py-
lori-infected on the mucosal IL-21 mRNA level in gastric 
mucosa. Finally, we determined the correlation between 
mucosal IL-21 mRNA levels and grade of gastritis.
Material and methods
Patients and sampling
A total of 86 subjects undergoing endoscopy at Hajar 
University Hospital, in Shahrekord, Iran, were included in 
the study. The study was approved by the Human Research 
Ethics Committee of Shahrekord University of Medical 
Sciences, and informed consent was obtained from each 
volunteer before participation. The groups were charac-
terised as follows: the H. pylori-positive group (n = 48: 
16 males, 32 females; mean age: 42.4 ±14.82 years); the 
H. pylori-negative group (n = 38: 18 males, 20 females; 
mean age: 38.18 ±16.51 years). Helicobacter pylori infec-
tion was determined by the rapid urease test, PCR (16s 
rRNA and glmM) and histological examination of biopsies 
taken from the antrum. Patients were classified as H. pylori 
infected only if the four tests were positive. Four biopsies 
were collected from H. pylori-infected patients, and used 
for rapid urease test, histological examination, assessment 
of bacterial virulence factors, detection of H. pylori, and 
cytokine RNA analysis. This study was approved by the 
Ethics Committee of Shahrekord University of Medical 
Sciences, Shahrekord, Iran.
Histological examination
Sections of biopsy specimens were embedded in 10% 
buffered formalin and stained with Haematoxylin and Eo-
sin to examine gastritis, and with Giemsa to detect H. pylo-
ri. The histological severity of gastritis (acute and chronic) 
was blindly graded from normal to severe based on the 
degree of mononuclear cell (MNC) and polymorphonucle-
ar leukocyte (PMN) infiltration according to the Updated 
Sydney system [22] on a four-point scale: 0, no; 1, mild; 
2, moderate; and 3, severe changes. The grade of chronic 
and active inflammation was investigated for involvement 
according to the density of neutrophils and mononuclear in 
gastric mucosal crypts, from one to all crypts.
Polymerase chain reaction amplification
DNA for polymerase chain reaction (PCR) was extract-
ed using the Biospin Tissue Genomic DNA Extraction Kit 
(BioFlux, Japan). Specific primers for PCR amplification 
of different genes are shown in Table 1. For vacA and 
cagA evaluation, the PCR program comprised 35 cycles 
of denaturation (at 94°C for 30 s), annealing (at 56°C for 
30 s, extension at 72°C for 30 s), and one final extension 
(at 72°C for 5 min).
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Quantitative analysis for interleukin-21 mRNA 
in the gastric mucosa using real-time polymerase 
chain reaction
Total RNA was isolated from whole gastric biopsy 
specimens using total RNA extraction biozol (Bioflux, 
Japan). An aliquot containing 0.2 μg of total RNA was 
used for the reverse transcription reaction, which was con-
ducted using the superscript first-strand cDNA synthesis 
system (Fermentas, Finland) according to the manufactur-
er’s instructions. The sequences of oligonucleotide prim-
er and probe are shown in Table 2. The quantification of 
IL-21 mRNA levels was performed using a Rotor-Gene 
3000 (Corbett). Real-time PCR reactions were performed 
in a total volume of 25 μl, containing 3 μl of synthesised 
cDNA solution, 12.5 μl of 2x Rotor-Gene Probe PCR 
Master Mix (Qiagen, Germany), 500 nM of each primer, 
and 250 nM of the TaqMan probe. Amplification program 
included a pre-warming step (10 min at 94oC), denatur-
ation step (94°C for 15 s), and an annealing/extension step 
(60°C for 60 s). The expression levels of cytokine mRNA 
were expressed as the ratio of cytokine mRNA to β-actin 
mRNA (cytokine mRNA/β-actin mRNA). Each assay was 
performed in duplicate, and each cytokine assay was per-
formed testing all RNA samples in the same experiment. 
Relative quantification of cytokine to β-actin (cytokine 
mRNA/β-actin mRNA) was determined using the 2−ΔCt = 
= 2− (Ct, IL-21− Ct, β-actin) method.
Statistical analysis
Data were analysed using GraphPad Prism 5 Demo 
(GraphPad Software, San Diego, California, USA). Data 
are expressed as raw and mean if not stated otherwise. Age 
was analysed by unpaired Student’s t-test. In statistics, nor-
mality tests were used to determine whether a data set was 
well modelled by a normal distribution or not, cytokine 
expression was presented as mean, and differences be-
tween infected and uninfected groups were analysed using 
Student’s t-test. Also for gene expression values between 
H. pylori-infected patients and virulence factors the para-
metric Student’s t-test was used, and for comparison of 
more than two groups one-way ANOVA test was used. 
Categorical data (between virulence factors) are present-
ed as frequencies; comparisons were made using the χ2 or 
Fisher exact test if < 5 samples were in one group. P values 
< 0.05 were considered to be statistically significant.
Results
Correlation of vacA alleles and presence  
of cagA gene
The correlation of s1 and s1m2 genotypes with cagA 
positive was statistically significant, and no correlation of 
m1 genotype was observed with cagA. The cagA gene was 
detected in 60.4% (29 strains) of H. pylori. The association 
between vacA alleles and the presence of virulence factors 
Table 1. Polymerase chain reaction primers for amplification of virulence factors
Size of PCR product (bp) Primer sequence Primer designation
567 bp (m1)
642 bp (m2)
vacAmF: 5-CAATCTGTCCAATCAAGCGAG-3
vacAmR: 5-GCGTCTAAATAATTCCAAGG-3
vacA m1/m2
259 bp (s1)
286 bp (s2)
VA1-F: 5-ATGGAAATACAACAAACACAC-3
VA1-R: 5-CTGCTTGAATGCGCCAAAC-3
vacA s1/s2
232 bp cag1: 5-ATGACTAACGAAACTATTGATC-3
cag2 5-CAGGATTTTTGATCGCTTTATT-3
cagA
Table 2. Primer and probe sequences employed in this 
study
Gene Primer and probe sequence
β-actin Forward 5-AGCCTCGCCTTTGCCGA-3
Reverse 5-CTGGTGCCTGGGGCG-3
Probe FAM-CCGCCGCCCG
TCCACACCCGCC-TAMRA
IL-21 Forward 5- TGTGAATGACTTGGTCCCTGAA-3
Reverse 5- AACAGGAAAAAGCTGACCACTCA-3
Probe FAM-TCTGCCAGCTCCAGAAGATG 
TAGAGACAAAC-TAMRA
Table 3. Correlation of vacA alleles with the cagA geno-
type of the samples studied
vacA genotype cagA
Positive
Negative
s1m1 7 4
s1m2 16 6
s2m2 2 6
P value 0.06
s1 26 11
s2 2 6
P value 0.018
m1 7 4
m2 22 14
P value 0.881
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is described in Table 3. Out of 29 H. pylori subjects that 
were positive for cagA, 26 strains were associated with the 
toxin-producing vacA s1, and only 2 cagA-positive strains 
were vacA s2 (p < 0.018). Sixteen strains were associated 
with the toxin-producing vacA s1m2, only 7 strains were 
vacA s1m2, and 2 strains were vacA s2m2 (p < 0.06).
Interleukin-21 expression in Helicobacter pylori-
infected gastric mucosa
Interleukin-21 expression was significantly greater 
in biopsy specimens of H. pylori infected patients com-
pared with H. pylori negative (Fig. 1). If the mean in the 
H. pylori-positive group is 0.00006 and the mean in the 
H. pylori-negative patients with gastritis is 0.000017, then 
the difference in the IL-21 mRNA expression in the H. 
pylori-positive patients compared with the H. pylori-nega-
tive patients with gastritis is 0.00006/0.000017, or 3.5 fold. 
Also, the difference in the IL-21 mRNA expression in 
the H. pylori-positive patients compared with the H. py-
lori-negative normal mucosa is 0.00006/0.0000027, or 
22.22 fold, and H. pylori-negative patients with gastritis 
compared with the H. pylori-negative normal mucosa is 
0.000017/0.0000027, or 6.3 fold.
The effect of vacA allelic variants in Helicobacter 
pylori infected on the mucosal interleukin-21 
mRNA level in gastric mucosa
Our results showed that in H. pylori-infected patients, 
the mucosal IL-21 mRNA level was independent of the 
vacA status. The difference in the IL-21 mRNA expression 
in the vacA s1-positive H. pylori strains compared with the 
vacA s2-positive H. pylori strains was 0.00008/0.000041, or 
1.95 fold. Mucosal IL-21 mRNA expression in H. pylori-in-
fected patients with vacA ml-positive was not significantly 
higher than those observed in H. pylori-infected patients 
with vacA m2-positive (0.00008/0.00007, or 1.19 fold). 
Also, mucosal IL-21 mRNA expression in gastritis patients 
with vacA s1ml-positive was not significantly higher than 
those observed in gastritis patients with vacA s1m2-positive 
(0.000084/0.000089, or 0.94 fold) and vacA s2m2-positive 
(0.000084/0.000041, or 2.05 fold).
The effect of cagA virulence factor in 
Helicobacter pylori infected on the mucosal 
interleukin-21 mRNA level in gastric mucosa
Mucosal IL-21 mRNA level was independent of cagA 
virulence factor status. If the mean H. pylori-positive 
Fig. 1. Relative expression level of interleukin (IL)-21 
mRNA in gastric mucosa shown by Helicobacter py-
lori status. RNA was extracted from gastric biopsies of 
48 H. pylori-infected patients, 26 H. pylori-negative patients 
with gastritis, 12 H. pylori-negative normal mucosa; and 
analysed for IL-21 by real-time polymerase chain reaction. 
Levels are normalised to β-actin. Statistical significance was 
evaluated using the one-way ANOVA test (*p < 0.05)
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Fig. 2. Relative expression levels of interleukin (IL)-21 mRNA in Helicobacter pylori-infected patients shown by grade 
of gastritis. The mucosal IL-21 mRNA level is positively correlated with the grade of chronic inflammation (A). Also, 
no correlation was seen between the mucosal IL-21 mRNA expression and the activity score (B). Statistical significance 
was evaluated using Student’s t-test (**p < 0.001; p > 0.99)
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group with cagA is 0.00007 and the mean H. pylori-posi-
tive group without cagA is 0.00003, then the difference in 
the IL-21 mRNA expression in the cagA-positive H. pylori 
strains compared with the cagA-negative H. pylori strains 
is 0.00007/0.00003, or 2.3 fold.
Correlation between mucosal interleukin-21 
mRNA levels and grade of gastritis
The degree of inflammatory activity was assessed and 
graded as follows: 54.1% (26) none, 39.6% (19) mild, and 
6.3% (3) moderate. As far as chronic inflammation was 
concerned, there were 37.5% (18) mild, 33.3% (16) mod-
erate, and 29.1% (14) severe in the studied population. Fig-
ure 2 shows the relationship between the mucosal IL-21 
mRNA expression and the activity (neutrophil infiltration) 
and chronic inflammation (mononuclear cell infiltration) 
scores. There was a significant correlation between the 
mucosal IL-21 mRNA expression and the chronic inflam-
mation scores. No correlation was observed between the 
mucosal IL-21 mRNA expression and the activity score.
Discussion
Our findings showed that the mucosal IL-21 mRNA 
level increased in the H. pylori-infected patients compared 
with uninfected patients and correlated positively with the 
degree of chronic inflammation in patients infected with H. 
pylori. Mucosal IL-21 mRNA expression was also indepen-
dent of the virulence factors of H. pylori. Similarly to other 
reports [23], we also found that the correlation of s1 and 
s1m2 genotypes with cagA-positive was statistically sig-
nificant, but no correlation between m1 genotype and cagA 
was observed. We concluded that the dominant genotypes 
of H. pylori in Iranian patients with chronic gastritis might 
be cagA-positive s1/m2. Interleukin-21 is over-produced 
in other Th1-associated infiammatory diseases of the gas-
tro-intestinal tract, such as H. pylori-related gastritis and 
celiac disease [24, 25]. The results of Caruso et al. indicate 
that IL-21 was over expressed in H. pylori-infected gas-
tric mucosa and gastric epithelial AGS cells response to 
IL-21, increasing production of matrix metalloproteinase 
2 (MMP-2) and MMP-9, (but not MMP-1, MMP-3, or 
MMP-7) which contribute to mucosal ulceration and epi-
thelial damage [24]. High IL-21 production was also doc-
umented in autoimmune diseases such as psoriasis [26], 
atopic dermatitis (AD) [27], systemic lupus erythemato-
sus (SLE) [28], graft-versus-host disease (GVHD) [29], 
and multiple sclerosis [30]. The data emerging from these 
studies show that IL-21 has broad effects on both innate 
and adaptive immune responses, and excessive production 
of IL-21 associates with destructive immune reactions in 
various organs. However, the basic mechanism underlying 
IL-21 synthesis in diseased organs remains to be clarified. 
The study by Sutherland et al. demonstrated that IL-21 
levels were increased in the pancreas as NOD mice de-
veloped diabetes, and that CD4+ and CD8+ T-cells infil-
trating the pancreas could respond to local IL-21 as they 
expressed IL-21R [31]. These data are consistent with re-
cent studies from the laboratories of Leonard and Sarvet-
nick [32], showing that IL-21R–/– NOD mice are protected 
from insulitis and type 1 diabetes. Interleukin-21 could 
also play a role in the pathogenesis of other immune-me-
diated pathologies as its levels were found to be up-regu-
lated in synovial tissue samples of patients with rheuma-
toid arthritis (RA) and in labial salivary gland sections of 
patients with Sjögren’s syndrome (SS), as well as in the 
plasma of patients with SS, patients with Behçet disease, 
and patients with Hashimoto’s thyroiditis [33]. A previous 
published study showed that IL-21 was not able to trig-
ger Th1 cell differentiation, but it could enhance ongoing 
Th1 cell responses. For example, Strengell et al. indicated 
that IL-21 enhanced interferon γ (IFN-γ) gene expression 
in activated human T cells and promoted the transcription 
of Th1-associated genes, including T-bet [34]. The same 
group also documented a synergistic effect of IL-21 and 
IL-15 or IL-21 and IL-18 on IFN-γ mRNA synthesis and 
production [35], whereas Kasaian et al. demonstrated that 
IL-21 cooperates with IL-2 and IL-15 in promoting IFN-γ 
synthesis [36]. Finally, a study previously showed that 
IL-21 enhanced T-bet and p-Stat4 expression and sustained 
IFN-γ synthesis in gut mucosal lymphocytes of patients 
with Crohn’s disease [20]. A recent study indicated an in-
crease in Th17 in H. pylori-infected patients and in human 
gastric tumours, and further showed that H. pylori-primed 
GMF (gastric myofibroblasts/fibroblasts) promoted differ-
entiation of TH-17. This process was dependent on IL-6, 
TGF-β1, and IL-21, which H. pylori-exposed and gastric 
tumour-derived MF (myofibroblast and fibroblast) pro-
duced at increased levels, consequently maintaining a stron-
ger ability to induce TH-17 cells. Their findings suggest 
that the enhanced TH-17 promoting capacity of the GMF, 
derived from gastric tumours, might be among the key fac-
tors contributing to gastric tumour-promoting inflammatory 
milieu [37]. Another study indicated that IL-21 expression 
was markedly higher in human gastric cancer mucosa com-
pared to normal [38]. Interleukin-21 can maintain chronic 
inflammation and/or favour tissue damage by promoting 
the recruitment of immune cells within the inflamed tissue 
[39], the expansion of autoreactive T cells [40], and the 
synthesis of extracellular matrix metalloproteinases [24].
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